Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1544 (3,5,3'-triiodothyronine, l-, Cyronine, Cytomel, Euthroid-0.5, Euthroid-1, Euthroid-2, Euthroid-3, Levothyroxine sodium related compound liothyronine, Liothyronine, NSC-80203, Rathyronine, Rathyronine, (s)-, Tertroxin, Thyrolar-0.25, Thyrolar-0.5, Thyrolar-1, Thyrolar-2, Thyrolar-3, Thyrolar-5, Triiodothyronine (T3 Or Liothyronine, Active) (6-11%), Triostat) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 6.62 | pKi | 239.7 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | B | 6.39 | pIC50 | 410.9 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Androgen receptor/Androgen Receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1871] [GtoPdb: 628] [UniProtKB: P10275] | ||||||||
ChEMBL | Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2011) 54: 8563-8573 [PMID:22047606] |
GABAA receptor π subunit/GABAA receptor δ subunit/GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABAA receptor α4 subunit/GABAA receptor ε subunit/GABAA receptor α6 subunit/GABAA receptor γ1 subunit/GABAA receptor γ3 subunit/GABAA receptor θ subunit/GABA-A receptor; anion channel in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2093872] [GtoPdb: 419, 416, 404, 410, 414, 412, 408, 406, 405, 411, 407, 417, 409, 413, 415, 418] [UniProtKB: O00591, O14764, P14867, P18505, P18507, P28472, P31644, P34903, P47869, P47870, P48169, P78334, Q16445, Q8N1C3, Q99928, Q9UN88] | ||||||||
ChEMBL | Direct channel-gating action blocked by picrotoxin | B | 4.64 | pIC50 | 23000 | nM | IC50 | J Med Chem (2000) 43: 1427-1447 [PMID:10780899] |
GABAA receptor π subunit/GABAA receptor β1 subunit/GABAA receptor δ subunit/GABAA receptor γ2 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor γ1 subunit/GABAA receptor α2 subunit/GABAA receptor α4 subunit/GABAA receptor γ3 subunit/GABAA receptor α6 subunit/GABAA receptor α1 subunit/GABAA receptor β3 subunit/GABAA receptor β2 subunit/GABAA receptor ε subunit/GABA-A receptor; anion channel in Rat (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL1907607] [GtoPdb: 419, 410, 416, 414, 408, 406, 413, 405, 407, 415, 409, 404, 412, 411, 417] [UniProtKB: O09028, P15431, P18506, P18508, P19969, P20236, P23574, P23576, P28471, P28473, P30191, P62813, P63079, P63138, Q91ZM7, Q9ES14] | ||||||||
ChEMBL | Non-competitive inhibitory activity against recombinant Gamma-aminobutyric acid A (GABA-A) receptor | B | 5.15 | pEC50 | 7000 | nM | EC50 | J Med Chem (2000) 43: 1427-1447 [PMID:10780899] |
Peroxisome proliferator-activated receptor-γ/Peroxisome proliferator-activated receptor gamma in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL235] [GtoPdb: 595] [UniProtKB: P37231] | ||||||||
ChEMBL | Binding affinity to recombinant PPARgamma LBD (unknown origin) by isothermal titration calorimetry | B | 6.15 | pKd | 710 | nM | Kd | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
ChEMBL | Agonist activity at recombinant human pFA-CMV fused PPARgamma expressed in HEK293T cells transfected with pFR-luciferase plasmid and pRL-SV40 plasmid incubated for 14 to 16 hrs by dual glo luciferase reporter gene assay | B | 5.24 | pEC50 | 5800 | nM | EC50 | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
Proliferating cell nuclear antigen in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2346488] [UniProtKB: P12004] | ||||||||
ChEMBL | Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay | B | 5.44 | pIC50 | 3600 | nM | IC50 | Bioorg Med Chem (2013) 21: 1972-1977 [PMID:23395113] |
Solute carrier organic anion transporter family member 1A4 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1781860] [UniProtKB: O35913] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of Digoxin uptake in Xenopus laevis oocytes | F | 4.3 | pIC50 | 50400 | nM | IC50 | J Pharmacol Exp Ther (2001) 299: 261-267 [PMID:11561088] |
OATP1C1/Solute carrier organic anion transporter family member 1C1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073688] [GtoPdb: 1222] [UniProtKB: Q9ERB5] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of L-T4 uptake in Oatp14-expressing HEK293 cells | F | 4.62 | pKi | 24200 | nM | Ki | Endocrinology (2004) 145: 4384-4391 [PMID:15166123] |
coagulation factor II, thrombin/Thrombin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL204] [GtoPdb: 2362] [UniProtKB: P00734] | ||||||||
ChEMBL | Agonist activity at human THRbeta expressed in CHO cells after 24 hrs by luciferase assay | B | 8.21 | pEC50 | 6.2 | nM | EC50 | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
ChEMBL | Agonist activity at GST-labelled THRbeta ( 202 to 461 residues) (unknown origin) incubated for 2 hrs in presence SRC1-2 co-activator peptide by Alphascreen assay | B | 8.92 | pEC50 | 1.2 | nM | EC50 | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
ChEMBL | Agonist activity at human THRbeta expressed in green monkey CV1 cells after 24 hrs by luciferase assay | B | 8.92 | pEC50 | 1.2 | nM | EC50 | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
Thyroid hormone receptor-α/Thyroid hormone receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1860] [GtoPdb: 588] [UniProtKB: P10827] | ||||||||
ChEMBL | Binding affinity towards thyroid hormone receptor (hTR alpha 1) | B | 9.77 | pKd | 0.17 | nM | Kd | Bioorg Med Chem Lett (2001) 11: 2821-2825 [PMID:11597408] |
GtoPdb | - | - | 10 | pKd | - | - | - | J Med Chem (2002) 45: 3310-20 [PMID:12109914] |
ChEMBL | Binding affinity against human Thyroid hormone receptor alpha-1 (hTRalpha1) using radiolabeled T3 | B | 10 | pKd | 0.1 | nM | Kd | J Med Chem (2002) 45: 3310-3320 [PMID:12109914] |
ChEMBL | Binding affinity of compound was determined against Thyroid hormone receptor alpha1 | B | 10.22 | pKd | 0.06 | nM | Kd | J Med Chem (2003) 46: 3152-3161 [PMID:12825953] |
ChEMBL | Displacement of [125I]T3 from human TRalpha receptor | B | 10.24 | pKd | 0.06 | nM | Kd | Bioorg Med Chem (2008) 16: 762-770 [PMID:17988877] |
ChEMBL | Displacement of [125I]T3 from human recombinant thyroid harmone receptor alpha after 16 to 48 hrs by gamma-ray detection | B | 8.63 | pKi | 2.33 | nM | Ki | Bioorg Med Chem (2012) 20: 3622-3634 [PMID:22542282] |
ChEMBL | Displacement of [125I]-T3 from human TRalpha expressed in insect cells after 16 to 48 hrs by gamma-counting | B | 8.63 | pKi | 2.33 | nM | Ki | Bioorg Med Chem (2013) 21: 592-607 [PMID:23276448] |
ChEMBL | Displacement of [125I]3,5,3'-triiodo-L-thyronine from His-tagged human recombinant TRalpha1 by scintillation proximity assay | B | 9.48 | pKi | 0.33 | nM | Ki | J Med Chem (2008) 51: 7075-7093 [PMID:18975928] |
ChEMBL | Displacement of [125I]T3 from recombinant thyroid hormone receptor alpha expressed in sf9 cells by scintillation proximity assay | B | 9.66 | pKi | 0.22 | nM | Ki | Proc Natl Acad Sci U S A (2007) 104: 15490-15495 [PMID:17878314] |
ChEMBL | Displacement of [125I]-Triiodothyronine from human recombinant TRalpha1 ligand binding domain after 2 to 3 hrs by beta counting | B | 8.49 | pIC50 | 3.2 | nM | IC50 | Bioorg Med Chem (2014) 22: 488-498 [PMID:24290064] |
ChEMBL | Inhibitory concentration against cloned human thyroid hormone receptor alpha 1 | B | 9.62 | pIC50 | 0.24 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4579-4584 [PMID:16099653] |
ChEMBL | Binding affinity at human thyroid hormone receptor alpha 1 expressed in CHOK1 cells | B | 9.62 | pIC50 | 0.24 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 4131-4134 [PMID:17543524] |
ChEMBL | Agonist activity at human THR-alpha expressed in CHO-K1 cells by PathHunter assay | B | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (2022) 65: 9974-10000 [PMID:35797110] |
ChEMBL | Agonist activity at wild type human TR alpha LBD expressed in Escherichia coli BL21 (DE3) assessed as induction of N-terminal biotinylated coactivator SRC2-3 peptide recruitment by alphascreen assay | B | 7.53 | pEC50 | 29.7 | nM | EC50 | J Med Chem (2022) 65: 7193-7211 [PMID:35507418] |
ChEMBL | Agonist activity at recombinant His6-tagged THR-alpha (unknown origin) expressed in Escherichia coli BL21(DE3) co-expressing RXR preincubated for 30 mins assessed as biotin-GRIP1 peptide recruitment by HTRF assay | B | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (2014) 57: 3912-3923 [PMID:24712661] |
ChEMBL | Agonist activity at human THRalpha expressed in CHO cells after 24 hrs by luciferase assay | B | 8.47 | pEC50 | 3.4 | nM | EC50 | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
ChEMBL | Effect on human TRalpha transactivation activity in HeLa cells by luciferase reporter assay | B | 8.62 | pEC50 | 2.4 | nM | EC50 | Bioorg Med Chem (2008) 16: 762-770 [PMID:17988877] |
ChEMBL | Effect on human TRalpha transactivation activity in U2OS cells by luciferase reporter assay | B | 8.62 | pEC50 | 2.4 | nM | EC50 | Bioorg Med Chem (2008) 16: 762-770 [PMID:17988877] |
ChEMBL | Agonist activity at human recombinant TRalpha1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assay | B | 8.68 | pEC50 | 2.1 | nM | EC50 | Bioorg Med Chem (2014) 22: 488-498 [PMID:24290064] |
ChEMBL | Half-maximum activation of human Thyroid hormone receptor alpha-1 (hTRalpha1) | B | 8.7 | pEC50 | 2 | nM | EC50 | J Med Chem (2002) 45: 3310-3320 [PMID:12109914] |
ChEMBL | Effective concentration binding towards TRalpha in E25B2 cells (agonistic activity) | B | 8.7 | pEC50 | 2 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 379-382 [PMID:12565933] |
ChEMBL | Agonist activity at human THRalpha transfected in Huh7 cells co-transfected with luciferase reporter plasmid assessed as reduction in luciferase activity incubated for 16 hrs by Steady-Glo luciferase assay | B | 9.15 | pEC50 | 0.7 | nM | EC50 | J Med Chem (2023) 66: 3284-3300 [PMID:36799411] |
ChEMBL | Agonist activity at human THRalpha expressed in baculovirus infected SF9 cells after 15 mins by gel electrophoresis | B | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2020) 63: 6727-6740 [PMID:32356658] |
ChEMBL | Agonist activity at human thyroid hormone receptor alpha expressed in HEK293 cells by luciferase reporter gene assay | B | 9.39 | pEC50 | 0.41 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 5265-5267 [PMID:25305688] |
Thyroid hormone receptor-β/Thyroid hormone receptor beta-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1947] [GtoPdb: 589] [UniProtKB: P10828] | ||||||||
ChEMBL | Binding affinity towards thyroid hormone receptor (hTR beta 1) | B | 9.85 | pKd | 0.14 | nM | Kd | Bioorg Med Chem Lett (2001) 11: 2821-2825 [PMID:11597408] |
ChEMBL | Binding affinity against human Thyroid hormone receptor beta 1 (hTRbeta1) using radiolabeled T3 | B | 10 | pKd | 0.1 | nM | Kd | J Med Chem (2002) 45: 3310-3320 [PMID:12109914] |
ChEMBL | Binding affinity of compound was determined against thyroid hormone receptor beta 1 | B | 10.06 | pKd | 0.09 | nM | Kd | J Med Chem (2003) 46: 3152-3161 [PMID:12825953] |
ChEMBL | Displacement of [125I]T3 from human TRbeta receptor | B | 10.09 | pKd | 0.08 | nM | Kd | Bioorg Med Chem (2008) 16: 762-770 [PMID:17988877] |
GtoPdb | - | - | 10.1 | pKd | - | - | - | J Med Chem (2002) 45: 3310-20 [PMID:12109914] |
ChEMBL | Displacement of [125I]T3 from human recombinant thyroid harmone receptor beta after 16 to 48 hrs by gamma-ray detection | B | 8.64 | pKi | 2.29 | nM | Ki | Bioorg Med Chem (2012) 20: 3622-3634 [PMID:22542282] |
ChEMBL | Displacement of [125I]-T3 from human TRbeta expressed in insect cells after 16 to 48 hrs by gamma-counting | B | 8.64 | pKi | 2.29 | nM | Ki | Bioorg Med Chem (2013) 21: 592-607 [PMID:23276448] |
ChEMBL | Displacement of [125I]3,5,3'-triiodo-L-thyronine His-tagged human recombinant TRbeta1 by scintillation proximity assay | B | 9.17 | pKi | 0.68 | nM | Ki | J Med Chem (2008) 51: 7075-7093 [PMID:18975928] |
ChEMBL | Displacement of [125I]T3 from recombinant thyroid hormone receptor beta expressed in sf9 cells by scintillation proximity assay | B | 9.26 | pKi | 0.55 | nM | Ki | Proc Natl Acad Sci U S A (2007) 104: 15490-15495 [PMID:17878314] |
ChEMBL | Inhibitory activity against [125I]T3 binding to human TRbeta1 receptor | B | 10.1 | pKi | 0.08 | nM | Ki | Bioorg Med Chem Lett (2003) 13: 379-382 [PMID:12565933] |
ChEMBL | Displacement of [125I]-Triiodothyronine from human recombinant TRbeta1 ligand binding domain after 2 to 3 hrs by beta counting | B | 8.54 | pIC50 | 2.9 | nM | IC50 | Bioorg Med Chem (2014) 22: 488-498 [PMID:24290064] |
ChEMBL | Inhibitory concentration against cloned human thyroid hormone receptor beta 1 | B | 9.59 | pIC50 | 0.26 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4579-4584 [PMID:16099653] |
ChEMBL | Binding affinity at human thyroid hormone receptor beta-1 expressed in CHOK1 cells | B | 9.59 | pIC50 | 0.26 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 4131-4134 [PMID:17543524] |
ChEMBL | Inhibition of human thyroid hormone receptor beta 1 | B | 9.59 | pIC50 | 0.26 | nM | IC50 | Bioorg Med Chem (2007) 15: 5251-5261 [PMID:17524652] |
ChEMBL | Agonist activity at human TR beta LBD (202 to 461 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as induction of N-terminal biotinylated coactivator SRC2-3 peptide recruitment by alphascreen assay | B | 7.45 | pEC50 | 35.2 | nM | EC50 | J Med Chem (2022) 65: 7193-7211 [PMID:35507418] |
ChEMBL | Agonist activity at recombinant His6-tagged THR-beta (unknown origin) expressed in Escherichia coli BL21(DE3) co-expressing RXR preincubated for 30 mins assessed as biotin-GRIP1 peptide recruitment by HTRF assay | B | 7.82 | pEC50 | 15 | nM | EC50 | J Med Chem (2014) 57: 3912-3923 [PMID:24712661] |
ChEMBL | Effect on human TRbeta transactivation activity in U2OS cells by luciferase reporter assay | B | 7.96 | pEC50 | 11 | nM | EC50 | Bioorg Med Chem (2008) 16: 762-770 [PMID:17988877] |
ChEMBL | Agonist activity at human THR-beta expressed in CHO-K1 cells by PathHunter assay | B | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (2022) 65: 9974-10000 [PMID:35797110] |
ChEMBL | Effect on human TRbeta transactivation activity in HeLa cells by luciferase reporter assay | B | 8.62 | pEC50 | 2.4 | nM | EC50 | Bioorg Med Chem (2008) 16: 762-770 [PMID:17988877] |
ChEMBL | Half-maximum activation of human Thyroid hormone receptor beta 1 (hTRbeta1) | B | 8.7 | pEC50 | 2 | nM | EC50 | J Med Chem (2002) 45: 3310-3320 [PMID:12109914] |
ChEMBL | Effective concentration binding towards TR-beta-1 in E25B2 cells (agonistic activity) | B | 8.7 | pEC50 | 2 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 379-382 [PMID:12565933] |
ChEMBL | Agonist activity at human recombinant TRbeta1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assay | B | 8.7 | pEC50 | 2 | nM | EC50 | Bioorg Med Chem (2014) 22: 488-498 [PMID:24290064] |
ChEMBL | Agonist activity at human THRbeta transfected in Huh7 cells co-transfected with luciferase reporter plasmid assessed as reduction in luciferase activity incubated for 16 hrs by Steady-Glo luciferase assay | B | 8.96 | pEC50 | 1.1 | nM | EC50 | J Med Chem (2023) 66: 3284-3300 [PMID:36799411] |
Thyroid hormone receptor-β/Thyroid hormone receptor beta-1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3917] [GtoPdb: 589] [UniProtKB: P18113] | ||||||||
ChEMBL | In vitro inhibition of bound [125I]L-T3 rat plasma membrane 3,5,3'' L-triiodothyronine receptor | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (1995) 38: 695-707 [PMID:7861417] |
ChEMBL | In vitro inhibition of bound [125I]L-T3 rat plasma membrane 3,5,3'' L-triiodothyronine receptor | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (1995) 38: 695-707 [PMID:7861417] |
ChEMBL | In vitro inhibition of the bound [125I]L-T3 rat liver nuclear L-triiodothyronine receptor | B | 8.36 | pIC50 | 4.4 | nM | IC50 | J Med Chem (1995) 38: 695-707 [PMID:7861417] |
ChEMBL | In vitro inhibition of the bound [125I]L-T3 rat liver nuclear L-triiodothyronine receptor | B | 8.74 | pIC50 | 1.8 | nM | IC50 | J Med Chem (1995) 38: 695-707 [PMID:7861417] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]